Ramipril 10mg Capsules

Manufacturer LUPIN PHARMACEUTICALS Active Ingredient Ramipril(RA mi pril) Pronunciation RA mi pril
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.It is used to help heart function after a heart attack.It is used to lower the chance of heart attack, stroke, and death in some people.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antihypertensive, Heart Failure Agent, Cardiovascular Risk Reduction Agent
đŸ§Ŧ
Pharmacologic Class
Angiotensin-Converting Enzyme (ACE) Inhibitor
🤰
Pregnancy Category
Contraindicated (formerly D in 2nd/3rd trimester, C in 1st)
✅
FDA Approved
Feb 1991
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Ramipril is a medication used to treat high blood pressure, heart failure, and to reduce the risk of heart attack, stroke, and death in certain high-risk patients. It works by relaxing blood vessels, which helps blood flow more easily and lowers blood pressure.
📋

How to Use This Medicine

Taking Your Medication

To get the most benefit from your medication, follow these steps:

Take your medication exactly as directed by your doctor.
Read all the information provided with your medication and follow the instructions carefully.
You can take your medication with or without food.
Take your medication at the same time every day to establish a routine.
Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start feeling well.
Swallow the medication whole; do not chew or crush it.
If you have trouble swallowing the capsule, you can sprinkle its contents onto applesauce or into apple juice. However, do not chew the mixture.
Alternatively, you can sprinkle the capsule contents into a glass of water.
If needed, you can prepare a dose in advance. After mixing, the prepared dose can be stored at room temperature for up to 24 hours or in the refrigerator for up to 48 hours.
Drink plenty of non-caffeinated liquids, unless your doctor advises you to limit your fluid intake.

Storing and Disposing of Your Medication

To ensure your medication remains effective and safe:

Store your medication at room temperature in a dry place, avoiding the bathroom.
Keep all medications in a secure location, out of the reach of children and pets.
Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so by your pharmacist or healthcare provider.
Check with your pharmacist for guidance on the best way to dispose of your medication. You may also have access to local drug take-back programs.

What to Do If You Miss a Dose

If you miss a dose of your medication:

Take the missed dose as soon as you remember.
If it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule.
* Do not take two doses at the same time or take extra doses to make up for the missed dose.
💡

Lifestyle & Tips

  • Take ramipril exactly as prescribed, usually once daily, with or without food.
  • Do not stop taking ramipril without consulting your doctor, even if you feel well.
  • Avoid potassium supplements or salt substitutes containing potassium unless advised by your doctor.
  • Limit alcohol intake, as it can increase the blood pressure-lowering effect.
  • Maintain a healthy diet (low in sodium, rich in fruits and vegetables), regular exercise, and manage stress to support blood pressure control.
  • Inform your doctor or dentist that you are taking ramipril before any surgery or dental procedures.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Varies by indication (e.g., Hypertension: 2.5-20 mg once daily; Heart Failure: 1.25-10 mg once daily)
Dose Range: 1.25 - 20 mg

Condition-Specific Dosing:

hypertension: Initial 2.5 mg once daily; maintenance 2.5-20 mg once daily. May be given as 2 divided doses if needed.
heart_failure_post_mi: Initial 2.5 mg twice daily; maintenance 5 mg twice daily. If hypotension occurs, reduce to 1.25 mg twice daily.
heart_failure_symptomatic: Initial 1.25-2.5 mg once daily; maintenance 2.5-10 mg once daily.
cardiovascular_risk_reduction: Initial 2.5 mg once daily for 1 week, then 5 mg once daily for 3 weeks, then increase to 10 mg once daily.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established (limited data, generally not recommended)
Adolescent: Not established (limited data, generally not recommended)
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No initial adjustment needed (CrCl > 60 mL/min)
Moderate: Initial dose 1.25 mg once daily (CrCl 30-60 mL/min); titrate cautiously to max 5 mg/day.
Severe: Initial dose 1.25 mg once daily (CrCl < 30 mL/min); titrate cautiously to max 5 mg/day.
Dialysis: Initial dose 1.25 mg once daily; titrate cautiously. Ramiprilat is poorly dialyzable.

Hepatic Impairment:

Mild: Initial dose 1.25 mg once daily; titrate cautiously. Monitor closely.
Moderate: Initial dose 1.25 mg once daily; titrate cautiously. Monitor closely.
Severe: Not recommended due to lack of data and potential for impaired metabolism.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Ramipril is a prodrug that is hydrolyzed to its active metabolite, ramiprilat. Ramiprilat inhibits angiotensin-converting enzyme (ACE), which prevents the conversion of angiotensin I to angiotensin II. This leads to decreased vasoconstriction, reduced aldosterone secretion (resulting in decreased sodium and water reabsorption and increased potassium retention), and increased bradykinin levels (a potent vasodilator). These actions result in reduced peripheral vascular resistance, decreased blood pressure, and improved cardiac output.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50-60% (of ramiprilat from ramipril)
Tmax: Ramipril: 1 hour; Ramiprilat: 2-4 hours
FoodEffect: Food does not significantly alter the extent of absorption, but may delay Tmax.

Distribution:

Vd: Approximately 90 L (ramiprilat)
ProteinBinding: Approximately 73% (ramipril), 56% (ramiprilat)
CnssPenetration: Limited

Elimination:

HalfLife: Ramipril: 1-2 hours; Ramiprilat: 13-17 hours (effective half-life due to tight binding to ACE)
Clearance: Not available (variable)
ExcretionRoute: Renal (approximately 60%), Fecal (approximately 40%)
Unchanged: Less than 2% (ramipril), approximately 6% (ramiprilat)
âąī¸

Pharmacodynamics

OnsetOfAction: 1-2 hours
PeakEffect: 3-6 hours
DurationOfAction: 24 hours (with once-daily dosing)

Safety & Warnings

âš ī¸

BLACK BOX WARNING

FETAL TOXICITY: When pregnancy is detected, discontinue ramipril as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of high potassium levels, such as:
+ Abnormal heartbeat
+ Confusion
+ Weakness, lightheadedness, or dizziness
+ Feeling like passing out
+ Numbness or tingling
+ Shortness of breath
Severe dizziness or fainting
Persistent cough
Severe stomach pain
Severe nausea or vomiting
Liver problems, which can be indicated by:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Stomach pain or upset
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes (jaundice)

Note that liver problems have been reported with similar medications, and in some cases, have been fatal.

Other Possible Side Effects

Most people experience either no side effects or only mild ones. However, if you notice any of the following side effects or any other unusual symptoms, contact your doctor or seek medical attention:

Dizziness or headache
Cough
* Fatigue or weakness

This is not an exhaustive list of potential side effects. If you have concerns or questions, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Swelling of the face, lips, tongue, or throat (angioedema) - seek immediate medical attention.
  • Severe dizziness or fainting (signs of low blood pressure).
  • Persistent dry cough.
  • Yellowing of the skin or eyes (jaundice), dark urine, or severe stomach pain (signs of liver problems).
  • Signs of high potassium (muscle weakness, fatigue, slow or irregular heartbeat).
  • Signs of infection (fever, sore throat) - may indicate low white blood cell count.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is crucial to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
A history of angioedema, a severe and potentially life-threatening reaction characterized by swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing, swallowing problems, or unusual hoarseness.
If you are taking a medication containing aliskiren, especially if you have diabetes or kidney problems.
Current or prior use of telmisartan.
Use of another medication similar to this one. If you are unsure, consult your doctor or pharmacist for clarification.
If you have taken a medication containing sacubitril within the last 36 hours.
* If you are breastfeeding. Note that you should not breastfeed while taking this medication.

This list is not exhaustive, and it is essential to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health issues. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
âš ī¸

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you understand how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position, and be cautious when climbing stairs.

Monitoring Your Condition
Regularly check your blood pressure as directed by your healthcare provider. Additionally, have your blood work checked as instructed by your doctor, and discuss the results with them.

Interactions with Other Substances
If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult your doctor. Similarly, if you are on a low-salt or salt-free diet, discuss this with your doctor to ensure safe use of this medication.

Infection Risk
This medication, similar to captopril, may cause a decrease in white blood cell count, increasing the risk of infection. This risk is higher in individuals with kidney problems, particularly those with other underlying health conditions. If you experience symptoms of infection, such as fever, chills, or sore throat, contact your doctor immediately.

Interactions with Over-the-Counter Products
If you have high blood pressure and are taking this medication, consult your doctor before using over-the-counter products that may increase blood pressure, including cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, and certain natural products or aids.

Alcohol Consumption
Discuss your alcohol consumption with your doctor before drinking while taking this medication.

Fluid Loss and Dehydration
Be cautious in hot weather or during physical activity, and drink plenty of fluids to prevent fluid loss. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.

Effectiveness in Black Patients
This medication may be less effective in lowering blood pressure in Black patients. In some cases, additional medication may be necessary. If you have questions or concerns, discuss them with your doctor.

Risk of Angioedema
A severe and potentially life-threatening reaction called angioedema has been associated with this medication. The risk of angioedema may be higher in Black patients.
🆘

Overdose Information

Overdose Symptoms:

  • Severe hypotension (low blood pressure)
  • Dizziness
  • Lightheadedness
  • Fainting
  • Tachycardia (fast heart rate)
  • Bradycardia (slow heart rate)
  • Shock
  • Electrolyte disturbances (especially hyperkalemia)
  • Renal failure

What to Do:

Call 911 or Poison Control (1-800-222-1222) immediately. Management is supportive, including intravenous fluids to restore blood pressure, and monitoring of vital signs, renal function, and electrolytes. Hemodialysis is not effective for removing ramiprilat.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or moderate to severe renal impairment)
  • Sacubitril/valsartan (Entresto) - concomitant use or within 36 hours of last dose of sacubitril/valsartan
🔴

Major Interactions

  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride)
  • Potassium supplements
  • NSAIDs (Nonsteroidal Anti-inflammatory Drugs) - may reduce antihypertensive effect and increase risk of renal impairment
  • Lithium - increased serum lithium levels and toxicity
  • mTOR inhibitors (e.g., everolimus, sirolimus, temsirolimus) - increased risk of angioedema
  • Neprilysin inhibitors (e.g., sacubitril) - increased risk of angioedema
  • Dual blockade of the Renin-Angiotensin System (RAS) with ARBs or aliskiren - increased risk of hypotension, hyperkalemia, and renal impairment
🟡

Moderate Interactions

  • Other antihypertensives (additive hypotensive effect)
  • Diuretics (initial excessive hypotension)
  • Insulin and oral hypoglycemic agents (increased risk of hypoglycemia)
  • Gold (parenteral) - nitritoid reactions (facial flushing, nausea, vomiting, hypotension)
  • Corticosteroids (may reduce antihypertensive effect)
đŸŸĸ

Minor Interactions

  • Alcohol (additive hypotensive effect)
  • Antacids (may decrease absorption, separate administration)

Monitoring

đŸ”Ŧ

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and guide initial dosing.

Timing: Prior to initiation

Serum Creatinine (SCr) and Blood Urea Nitrogen (BUN)

Rationale: To assess baseline renal function, as ramipril is renally eliminated and can affect renal function.

Timing: Prior to initiation

Serum Potassium (K+)

Rationale: To assess baseline potassium levels, as ramipril can cause hyperkalemia.

Timing: Prior to initiation

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, especially after dose adjustments and during maintenance therapy.

Target: <130/80 mmHg (or individualized target)

Action Threshold: Hypotension (e.g., SBP <90 mmHg or symptomatic) or uncontrolled hypertension.

Serum Creatinine (SCr) and Blood Urea Nitrogen (BUN)

Frequency: Within 1-2 weeks of initiation or dose increase, then periodically (e.g., every 3-6 months) or as clinically indicated.

Target: Stable, within normal limits or acceptable baseline variation.

Action Threshold: Significant increase (e.g., >30% above baseline or >0.5 mg/dL increase) or signs of acute kidney injury.

Serum Potassium (K+)

Frequency: Within 1-2 weeks of initiation or dose increase, then periodically (e.g., every 3-6 months) or as clinically indicated, especially in patients with renal impairment, diabetes, or on potassium-sparing diuretics.

Target: 3.5-5.0 mEq/L

Action Threshold: >5.5 mEq/L (hyperkalemia) or symptomatic hypokalemia (if on concomitant diuretics).

đŸ‘ī¸

Symptom Monitoring

  • Signs of angioedema (swelling of face, lips, tongue, throat, difficulty breathing/swallowing)
  • Symptoms of hypotension (dizziness, lightheadedness, fainting)
  • Persistent dry cough
  • Symptoms of hyperkalemia (muscle weakness, fatigue, paresthesias, bradycardia, irregular heartbeat)
  • Signs of liver dysfunction (jaundice, dark urine, abdominal pain)
  • Symptoms of neutropenia (fever, sore throat, signs of infection)

Special Patient Groups

🤰

Pregnancy

CONTRAINDICATED. Ramipril can cause injury and death to the developing fetus. If pregnancy is detected, discontinue ramipril as soon as possible.

Trimester-Specific Risks:

First Trimester: Limited data, but potential for fetal harm cannot be excluded. Exposure during the first trimester is not associated with the specific fetotoxic effects seen with second and third trimester exposure, but alternative antihypertensive agents with better safety profiles are preferred.
Second Trimester: Significant risk of fetal injury and death, including fetal hypotension, anuria, oligohydramnios, skull hypoplasia, lung hypoplasia, skeletal deformations, and death.
Third Trimester: Significant risk of fetal injury and death, including fetal hypotension, anuria, oligohydramnios, skull hypoplasia, lung hypoplasia, skeletal deformations, and death. Neonatal adverse effects include hypotension, hyperkalemia, and renal failure.
🤱

Lactation

Use with caution. Ramipril and its metabolites are excreted in breast milk in very low amounts. The risk to the infant is considered low, but monitor for hypotension, hyperkalemia, and renal function.

Infant Risk: Low
đŸ‘ļ

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Use is generally not recommended.

👴

Geriatric Use

Start with lower doses (e.g., 1.25 mg once daily) and titrate cautiously, as elderly patients may have reduced renal function and be more sensitive to the hypotensive effects. Monitor renal function and potassium levels closely.

Clinical Information

💎

Clinical Pearls

  • Ramipril is a prodrug; its active metabolite, ramiprilat, is responsible for its therapeutic effects.
  • A persistent dry cough is a common side effect of ACE inhibitors, occurring in 5-20% of patients. If bothersome, an alternative class (e.g., ARB) may be considered.
  • Angioedema is a rare but potentially life-threatening side effect. Patients should be educated on symptoms and advised to seek immediate medical attention if it occurs.
  • Hyperkalemia risk is increased in patients with renal impairment, diabetes, or those taking potassium-sparing diuretics, potassium supplements, or NSAIDs.
  • First-dose hypotension can occur, especially in patients who are volume-depleted (e.g., on diuretics). Consider discontinuing diuretics 2-3 days prior to initiation if possible, or starting with a very low dose.
  • Ramipril is effective for cardiovascular risk reduction beyond just blood pressure lowering, particularly in patients with high cardiovascular risk (e.g., history of MI, stroke, or diabetes with at least one other CV risk factor).
🔄

Alternative Therapies

  • Other ACE inhibitors (e.g., lisinopril, enalapril, perindopril)
  • Angiotensin Receptor Blockers (ARBs) (e.g., valsartan, losartan, candesartan)
  • Beta-blockers (e.g., metoprolol, carvedilol)
  • Calcium Channel Blockers (CCBs) (e.g., amlodipine, nifedipine)
  • Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone)
  • Direct Renin Inhibitors (e.g., aliskiren - limited use)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 (Generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.